Skip to Content

Bakhu Holdings Corp BKUH

Morningstar Rating
$0.25 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BKUH is trading at a 55% discount.
Price
$0.25
Fair Value
$8.55
Uncertainty
Extreme
1-Star Price
$1.43
5-Star Price
$5.58
Economic Moat
Fwvsfyz
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BKUH is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.25
Day Range
$0.250.25
52-Week Range
$0.011.11
Bid/Ask
$0.01 / $0.50
Market Cap
$75.33 Mil
Volume/Avg
138 / 4,723

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Bakhu Holdings Corp is a development stage company engaged in the production, manufacturing, and sale of cannabis and byproducts. The company also provides cannabis-related research, teaching and education for both medical and other purposes, and all medical uses and applications of cannabis, within the Territory.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees
1

Comparables

Valuation

Metric
BKUH
TRUL
SCLX
Price/Earnings (Normalized)
69.49
Price/Book Value
1.56
Price/Sales
1.952.51
Price/Cash Flow
79.32
Price/Earnings
BKUH
TRUL
SCLX

Financial Strength

Metric
BKUH
TRUL
SCLX
Quick Ratio
0.141.870.15
Current Ratio
0.144.160.19
Interest Coverage
−7.04−2.56−106.04
Quick Ratio
BKUH
TRUL
SCLX

Profitability

Metric
BKUH
TRUL
SCLX
Return on Assets (Normalized)
174.31%−3.80%−106.47%
Return on Equity (Normalized)
−7.03%
Return on Invested Capital (Normalized)
−2.14%−1,960.39%
Return on Assets
BKUH
TRUL
SCLX
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ACmdcbnlhnXxskx$70.0 Bil
MKKGY
Merck KGaA ADRRdvwmwyjjMbcppp$68.1 Bil
HLN
Haleon PLC ADRBzlgblrpgLsvw$36.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRLslyffdmLwl$14.3 Bil
VTRS
Viatris IncQvphzplLrl$13.2 Bil
RDY
Dr Reddy's Laboratories Ltd ADRTldvppykxZttkj$11.9 Bil
CTLT
Catalent IncZrzgdqtNhhgg$10.1 Bil
PRGO
Perrigo Co PLCTsmcfxpPxjbb$4.1 Bil
CURLF
Curaleaf Holdings IncLvpbcmpHmblp$3.7 Bil
PBH
Prestige Consumer Healthcare IncJnnzkjgtpKtwby$3.4 Bil

Sponsor Center